⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12423958 | 0.76 | — | — | |
| SCHEMBL6384220 | 0.73 | — | — | |
| SCHEMBL22423718 | 0.69 | TSHR (0.52) | — | |
| SCHEMBL11458742 | 0.67 | — | — | |
| SCHEMBL18780014 | 0.67 | — | — | |
| SCHEMBL7142728 | 0.67 | — | — | |
| SCHEMBL30695852 | 0.65 | — | — | |
| SCHEMBL18911348 | 0.64 | — | — | |
| SCHEMBL28113699 | 0.63 | TSHR (0.35) | — | |
| SCHEMBL205358 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11135190-B2 | Levothyroxine liquid formulations | FRESENIUS KABI USA, LLC (US) | 2021-10-05 | — | — | US | claimed |
| US-20190336463-A1 | LEVOTHYROXINE LIQUID FORMULATIONS | FRESENIUS KABI USA, LLC (US) | 2019-11-07 | — | — | US | claimed |
| US-20180153838-A1 | LEVOTHYROXINE LIQUID FORMULATIONS | FRESENIUS KABI USA, LLC (US) | 2018-06-07 | — | — | US | claimed |
| EP-1748798-B1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | BAUSCH & LOMB (US) | 2010-05-05 | — | — | EP | claimed |
| US-7632869-B2 | Antimicrobial compositions and uses thereof | BAUSCH & LOMB INCORPORATED (US) | 2009-12-15 | — | — | US | claimed |
| US-7192937-B2 | Oligosaccharide-containing compositions and uses thereof | BAUSCH & LOMB INCORPORATED (US) | 2007-03-20 | — | — | US | claimed |
| EP-1748798-A1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | BAUSCH & LOMB INCORPORATED (US) | 2007-02-07 | — | — | EP | claimed |
| WO-2007002780-A2 | TOPICAL PRESERVATIVE COMPOSITIONS | BAUSCH & LOMB INCORPORATED (US) | 2007-01-04 | — | — | WO | claimed |
| US-20060292105-A1 | Topical preservative compositions | BAUSCH & LOMB INCORPORATED | 2006-12-28 | — | — | US | claimed |
| WO-2006014194-A1 | OLIGOSACCHARIDE-CONTAINING COMPOSITIONS AND USES THEREOF | BAUSCH & LOMB INCORPORATED (US) | 2006-02-09 | — | — | WO | claimed |
| WO-2005115487-A1 | ENHANCED DISINFECTING COMPOSITIONS FOR MEDICAL DEVICE TREATMENTS | BAUSCH & LOMB INCORPORATED (US) | 2005-12-08 | — | — | WO | claimed |
| WO-2005115485-A1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | BAUSCH & LOMB INCORPORATED (US) | 2005-12-08 | — | — | WO | claimed |
| US-20050260099-A1 | Antimicrobial compositions and uses thereof | BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) | 2005-11-24 | — | — | US | claimed |
| US-20050261148-A1 | Enhanced disinfecting compositions for medical device treatments | BAUSCH & LOMB INCORPORATED | 2005-11-24 | — | — | US | claimed |
| US-20050260098-A1 | Oligosaccharide-containing compositions and uses thereof | MEDICIS PHARMACEUTICAL CORPORATION | 2005-11-24 | — | — | US | claimed |
| US-20210386699-A1 | LIQUID READY-TO-USE FORMULATION OF LEVOTHYROXINE | SOMERSET THERAPEUTICS LLC (US) | 2021-12-16 | — | — | US | disclosed |
| US-11135190-B2 | Levothyroxine liquid formulations | FRESENIUS KABI USA, LLC (US) | 2021-10-05 | — | — | US | disclosed |
| CN-1240361-A | Use of low molecular weight amino alcohols in ophthalmic compositions | ALCON LAB INC (US) | 2000-01-05 | — | — | CN | disclosed |
| EP-0948357-A1 | USE OF LOW MOLECULAR WEIGHT AMINO ALCOHOLS IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1998025649-A1 | USE OF LOW MOLECULAR WEIGHT AMINO ALCOHOLS IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1998-06-18 | — | — | WO | disclosed |